Open AccessEarly experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs
Author(s) -
Nathalie Vernaz,
Thomas Agoritsas,
Alexandra Calmy,
Angèle Gayet-Ageron,
Gabriel Gold,
Arnaud Perrier,
Fabienne Picard,
Virginie Prendki,
Jean Luc Reny,
Caroline Flora Samer,
Jérôme Stirnemann,
Pauline Vetter,
Marie-Céline Zanella,
Dina Zekry,
Stéphanie Baggio
Publication year - 2020
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2020.20446
Subject(s) - medicine , hydroxychloroquine , lopinavir , ritonavir , lopinavir/ritonavir , confidence interval , propensity score matching , retrospective cohort study , emergency medicine , observational study , pediatrics , covid-19 , disease , human immunodeficiency virus (hiv) , viral load , family medicine , antiretroviral therapy , infectious disease (medical specialty)